Status:
COMPLETED
NAPLS Omega-3 Fatty Acid Versus Placebo Study
Lead Sponsor:
University of California, San Diego
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Psychosis
Eligibility:
All Genders
12-30 years
Phase:
PHASE1
Brief Summary
The overall goal of the present study is to determine whether Omega-3 Fatty Acids potentially prevent onset of psychosis and improve clinical symptoms and functional outcome in youth and young adults ...
Detailed Description
Recruitment of subjects for clinical assessment and testing with dependent measures is considered for research purposes. Use will be made of existing data and records as the data obtained from this pr...
Eligibility Criteria
Inclusion
- Subjects will be included if they are treatment-seeking patients between the ages of 12 and 30 who meet diagnostic criteria for a possible prodromal syndrome and are part of the ongoing NAPLS study.
Exclusion
- use of antipsychotic medication in the previous month.
- concomitant medical or neurological illness.
- history of significant head injury.
- alcohol or drug abuse (excluding nicotine) in the past month or dependence in the past three months.
- screening full scale estimated IQ \< 80.
- active suicidal or homicidal ideation.
- pregnancy or lactation.
- allergies to seafood or seafood related products or no history of seafood consumption
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
127 Patients enrolled
Trial Details
Trial ID
NCT01429454
Start Date
August 1 2011
End Date
June 1 2016
Last Update
February 25 2021
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Los Angeles
Los Angeles, California, United States, 90095
2
University of California, San Diego
San Diego, California, United States, 92093
3
Yale University
New Haven, Connecticut, United States, 06519
4
Emory University
Atlanta, Georgia, United States, 30322